The Cigna Group Registered Shs Aktie

The Cigna Group Registered Shs für 0 Euro bei ZERO ordern (zzgl. Spreads)

WKN DE: A2PA9L / ISIN: US1255231003

<
Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch
>
<
News + Analysen
News + Adhoc
Analysen
Kursziele
>
<
Unternehmen
Termine
Profil
>
<
zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs
>
07.03.2024 13:13:50

Cigna Group Raises Long-term Average Annual Adj. EPS Growth Target - Quick Facts

(RTTNews) - The Cigna Group (CI) increased its long-term average annual adjusted EPS growth target to 10%-14%. Also, the company reaffirmed its 2024 adjusted EPS guidance of at least $28.25.

The company also announced a series of solutions: Express Scripts by Evernorth; Evernorth Behavioral Health; and Evernorth Health Services. Evernorth is launching the industry's first financial guarantee for GLP-1s through EncircleRx. Evernorth Behavioral Care Group provides value-based, outcome-driven care through a simpler care delivery experience. Evernorth Health Services plans to have a Humira biosimilar available for $0 out of pocket to eligible patients of its specialty pharmacy Accredo later in the current year.

For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com.

Analysen zu The Cigna Group Registered Shsmehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

The Cigna Group Registered Shs 298,30 0,37% The Cigna Group Registered Shs